Literature DB >> 15638792

Pharmacological properties of furoxans and benzofuroxans: recent developments.

Hugo Cerecetto1, Williams Porcal.   

Abstract

The chemistry of furoxans (1, 2, 5-oxadiazole-2-oxides) and benzofuroxans (benzo[1, 2-c]1, 2, 5-oxadiazole-1-oxides) is very well known. These systems are widely used in organic chemistry as intermediate compounds for the synthesis of numerous heterocycles. In the other hand, furoxan and benzofuroxan derivatives were extensively studied as bioactive compounds. They possess remarkable biological activities, such as anti-microbial and anti-parasitic properties, mutagenic, immunosuppressive and anticancer effects, anti-aggregating and vasorelaxant activity, among others. In some cases, molecular mode of action was proposed. Recently, the research and development in the medicinal chemistry of these systems have produced hybrid compounds in which furoxan or benzofuroxan moieties together with a classical drug moieties are present in a single molecule. So, new anti-ulcer drugs, calcium channel modulators and vasodilator derivatives were described and they are currently in study. In this presentation recent developments in the medicinal chemistry of furoxans and benzofuroxans will be reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15638792     DOI: 10.2174/1389557053402864

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  10 in total

1.  Identification of oxadiazoles as new drug leads for the control of schistosomiasis.

Authors:  Ahmed A Sayed; Anton Simeonov; Craig J Thomas; James Inglese; Christopher P Austin; David L Williams
Journal:  Nat Med       Date:  2008-03-16       Impact factor: 53.440

2.  The study of NADPH-dependent flavoenzyme-catalyzed reduction of benzo[1,2-c]1,2,5-oxadiazole N-oxides (benzofuroxans).

Authors:  Jonas Šarlauskas; Lina Misevičienė; Audronė Marozienė; Laimonas Karvelis; Jonita Stankevičiūtė; Kastis Krikštopaitis; Narimantas Čėnas; Aleksey Yantsevich; Audrius Laurynėnas; Žilvinas Anusevičius
Journal:  Int J Mol Sci       Date:  2014-12-15       Impact factor: 5.923

Review 3.  Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules.

Authors:  Joanna Fedorowicz; Jarosław Sączewski
Journal:  Monatsh Chem       Date:  2018-06-07       Impact factor: 1.451

4.  C-C Coupling Reactions between Benzofurazan Derivatives and 1,3-Diaminobenzenes.

Authors:  Gabriele Micheletti; Silvia Bordoni; Elena Chugunova; Carla Boga
Journal:  Molecules       Date:  2017-04-26       Impact factor: 4.411

5.  Highly conjugated architectures and labile reaction intermediates from coupling between 10π electron-deficient heteroaromatics and sym-trihydroxy- or triamino-benzene derivatives.

Authors:  Gabriele Micheletti; Carla Boga; Silvia Cino; Silvia Bordoni; Elena Chugunova
Journal:  RSC Adv       Date:  2018-12-13       Impact factor: 4.036

6.  Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade.

Authors:  Anton Simeonov; Ajit Jadhav; Ahmed A Sayed; Yuhong Wang; Michael E Nelson; Craig J Thomas; James Inglese; David L Williams; Christopher P Austin
Journal:  PLoS Negl Trop Dis       Date:  2008-01-02

7.  Effects of the New Aldose Reductase Inhibitor Benzofuroxane Derivative BF-5m on High Glucose Induced Prolongation of Cardiac QT Interval and Increase of Coronary Perfusion Pressure.

Authors:  C Di Filippo; B Ferraro; R Maisto; M C Trotta; N Di Carluccio; S Sartini; C La Motta; F Ferraraccio; F Rossi; M D'Amico
Journal:  J Diabetes Res       Date:  2015-12-29       Impact factor: 4.011

8.  Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity.

Authors:  Guilherme Felipe Dos Santos Fernandes; Paula Carolina de Souza; Elsa Moreno-Viguri; Mery Santivañez-Veliz; Rocio Paucar; Silvia Pérez-Silanes; Konstantin Chegaev; Stefano Guglielmo; Loretta Lazzarato; Roberta Fruttero; Chung Man Chin; Patricia Bento da Silva; Marlus Chorilli; Mariana Cristina Solcia; Camila Maríngolo Ribeiro; Caio Sander Paiva Silva; Leonardo Biancolino Marino; Priscila Longhin Bosquesi; Debbie M Hunt; Luiz Pedro S de Carvalho; Carlos Alberto de Souza Costa; Sang Hyun Cho; Yuehong Wang; Scott Gary Franzblau; Fernando Rogério Pavan; Jean Leandro Dos Santos
Journal:  J Med Chem       Date:  2017-10-16       Impact factor: 7.446

9.  4,6-Dichloro-5-Nitrobenzofuroxan: Different Polymorphisms and DFT Investigation of Its Reactivity with Nucleophiles.

Authors:  Elena Chugunova; Nurgali Akylbekov; Alexey Dobrynin; Alexander Burilov; Carla Boga; Gabriele Micheletti; Vincenzo Frenna; Edoardo Jun Mattioli; Matteo Calvaresi; Domenico Spinelli
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

10.  Greener Synthesis of Antiproliferative Furoxans via Multicomponent Reactions.

Authors:  Mariana Ingold; Victoria de la Sovera; Rosina Dapueto; Paola Hernández; Williams Porcal; Gloria V López
Journal:  Molecules       Date:  2022-03-08       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.